{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:56:23Z","timestamp":1794563783827,"version":"4.9.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ganzhou Science and Technology Project","award":["2025YLCE0079"],"award-info":[{"award-number":["2025YLCE0079"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04215-8","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T09:34:04Z","timestamp":1769420044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Research progress on early diagnostic markers for pancreatic cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Luwei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3772-5826","authenticated-orcid":false,"given":"Yuanpeng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"4215_CR1","doi-asserted-by":"crossref","unstructured":"Drizyte-Miller K et al. KRAS: the Achilles\u2019 heel of pancreas cancer biology. J Clin Invest. 2025;135(16):141\u201357.","DOI":"10.1172\/JCI191939"},{"issue":"48","key":"4215_CR2","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.3748\/wjg.v28.i48.6827","volume":"28","author":"CY Zhang","year":"2022","unstructured":"Zhang CY, Liu S, Yang M. Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options. World J Gastroenterol. 2022;28(48):6827\u201345.","journal-title":"World J Gastroenterol"},{"issue":"31","key":"4215_CR3","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.3748\/wjg.v28.i31.4235","volume":"28","author":"V Tonini","year":"2022","unstructured":"Tonini V, Zanni M. Early diagnosis of pancreatic cancer: what strategies to avoid a foretold catastrophe. World J Gastroenterol. 2022;28(31):4235\u201348.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4215_CR4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13045-024-01613-x","volume":"17","author":"J Wang","year":"2024","unstructured":"Wang J, et al. Consensus, debate, and prospective on pancreatic cancer treatments. J Hematol Oncol. 2024;17(1):92.","journal-title":"J Hematol Oncol"},{"key":"4215_CR5","doi-asserted-by":"crossref","unstructured":"Mannucci A, Goel A. Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future. CA Cancer J Clin. 2026;76(1):e70035.","DOI":"10.3322\/caac.70035"},{"issue":"27","key":"4215_CR6","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.3748\/wjg.v27.i27.4298","volume":"27","author":"JX Hu","year":"2021","unstructured":"Hu JX, et al. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World J Gastroenterol. 2021;27(27):4298\u2013321.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"4215_CR7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.32604\/or.2023.028905","volume":"31","author":"H Yang","year":"2023","unstructured":"Yang H, et al. Progress on diagnostic and prognostic markers of pancreatic cancer. Oncol Res. 2023;31(2):83\u201399.","journal-title":"Oncol Res"},{"key":"4215_CR8","doi-asserted-by":"crossref","first-page":"e073995","DOI":"10.1136\/bmj-2022-073995","volume":"383","author":"M Del Chiaro","year":"2023","unstructured":"Del Chiaro M, et al. Advances in the management of pancreatic cancer. BMJ. 2023;383:e073995.","journal-title":"BMJ"},{"key":"4215_CR9","doi-asserted-by":"crossref","first-page":"120080","DOI":"10.1016\/j.cca.2024.120080","volume":"567","author":"X Gong","year":"2025","unstructured":"Gong X, et al. DUPAN-2 in pancreatic cancer: systematic review and meta-analysis. Clin Chim Acta. 2025;567:120080.","journal-title":"Clin Chim Acta"},{"key":"4215_CR10","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1245\/s10434-023-13564-7","volume":"30","author":"Y Shimizu","year":"2023","unstructured":"Shimizu Y, et al. Prognostic role of preoperative Duke pancreatic monoclonal antigen type 2 levels in patients with pancreatic cancer. Ann Surg Oncol. 2023;30:5792\u2013800.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"4215_CR11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10689-024-00381-4","volume":"23","author":"M Goggins","year":"2024","unstructured":"Goggins M. The role of biomarkers in the early detection of pancreatic cancer. Fam Cancer. 2024;23(3):309\u201322.","journal-title":"Fam Cancer"},{"key":"4215_CR12","doi-asserted-by":"crossref","first-page":"e16930","DOI":"10.7717\/peerj.16930","volume":"12","author":"S Guo","year":"2024","unstructured":"Guo S, et al. The role of CEMIP in cancers and its transcriptional and post-transcriptional regulation. PeerJ. 2024;12:e16930.","journal-title":"PeerJ"},{"issue":"1","key":"4215_CR13","doi-asserted-by":"crossref","first-page":"23729","DOI":"10.1038\/s41598-025-07911-9","volume":"15","author":"RAE Zohne","year":"2025","unstructured":"Zohne RAE, et al. Evaluation of CEMIP in diagnosis of pancreatic carcinoma in comparison with other traditional markers. Sci Rep. 2025;15(1):23729.","journal-title":"Sci Rep"},{"key":"4215_CR14","doi-asserted-by":"crossref","unstructured":"Mboumba-Mboumba M et al. The High Prevalence of Oncogenic HPV Genotypes Targeted by the Nonavalent HPV Vaccine in HIV-Infected Women Urgently Reinforces the Need for Prophylactic Vaccination in Key Female Populations Living in Gabon. Diseases. 2025;13(8):260.","DOI":"10.3390\/diseases13080260"},{"key":"4215_CR15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1146\/annurev-pathol-012414-040438","volume":"10","author":"SR Stowell","year":"2015","unstructured":"Stowell SR, Ju T, Cummings RD. Protein glycosylation in cancer. Annu Rev Pathol. 2015;10:473\u2013510.","journal-title":"Annu Rev Pathol"},{"key":"4215_CR16","doi-asserted-by":"crossref","unstructured":"Vitale F et al. The Past, Present, and Future of Biomarkers for the Early Diagnosis of Pancreatic Cancer. Biomedicines. 2024;12(12):2840.","DOI":"10.3390\/biomedicines12122840"},{"issue":"6","key":"4215_CR17","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s13304-023-01587-4","volume":"75","author":"N Napoli","year":"2023","unstructured":"Napoli N, et al. Ca 125 is an independent prognostic marker in resected pancreatic cancer of the head of the pancreas. Updates Surg. 2023;75(6):1481\u201396.","journal-title":"Updates Surg"},{"key":"4215_CR18","first-page":"2515690x2311983","volume":"28","author":"AAM Foda","year":"2023","unstructured":"Foda AAM, et al. Clinicopathological characteristics and prognosis of diffuse large B-Cell lymphoma in relation to CA-125 and CA 19\u2009\u2013\u20099 expression. J Evid Based Integr Med. 2023;28:2515690x231198315.","journal-title":"J Evid Based Integr Med"},{"issue":"1","key":"4215_CR19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s12951-021-01149-z","volume":"19","author":"H Qu","year":"2021","unstructured":"Qu H, et al. Recent advances of fluorescent biosensors based on Cyclic signal amplification technology in biomedical detection. J Nanobiotechnol. 2021;19(1):403.","journal-title":"J Nanobiotechnol"},{"issue":"26","key":"4215_CR20","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.3748\/wjg.v27.i26.4045","volume":"27","author":"RS O\u2019Neill","year":"2021","unstructured":"O\u2019Neill RS, Stoita A. Biomarkers in the diagnosis of pancreatic cancer: are we closer to finding the golden ticket? World J Gastroenterol. 2021;27(26):4045\u201387.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"4215_CR21","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s10620-023-07904-6","volume":"68","author":"MJ Amaral","year":"2023","unstructured":"Amaral MJ, et al. Pancreatic cancer biomarkers: oncogenic Mutations, tissue and liquid Biopsies, and Radiomics-A review. Dig Dis Sci. 2023;68(7):2811\u201323.","journal-title":"Dig Dis Sci"},{"key":"4215_CR22","doi-asserted-by":"crossref","unstructured":"Vellan CJ et al. Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review. Int J Mol Sci. 2022;23(4):2093.","DOI":"10.3390\/ijms23042093"},{"issue":"12","key":"4215_CR23","doi-asserted-by":"crossref","first-page":"e7388","DOI":"10.1002\/cam4.7388","volume":"13","author":"YS Wang","year":"2024","unstructured":"Wang YS, et al. Diagnostic value of carbohydrate antigen 50 in biliary tract cancer: A large-scale multicenter study. Cancer Med. 2024;13(12):e7388.","journal-title":"Cancer Med"},{"key":"4215_CR24","doi-asserted-by":"crossref","unstructured":"Luang S et al. Carbohydrate Antigen 50: Values for Diagnosis and Prognostic Prediction of Intrahepatic Cholangiocarcinoma. Medicina (Kaunas). 2020;56(11):616.","DOI":"10.3390\/medicina56110616"},{"issue":"1","key":"4215_CR25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12957-022-02785-x","volume":"20","author":"J Su","year":"2022","unstructured":"Su J, et al. Value of multi-detector computed tomography combined with serum tumor markers in diagnosis, preoperative, and prognostic evaluation of pancreatic cancer. World J Surg Oncol. 2022;20(1):323.","journal-title":"World J Surg Oncol"},{"key":"4215_CR26","doi-asserted-by":"crossref","first-page":"156045","DOI":"10.1016\/j.prp.2025.156045","volume":"272","author":"Z Yousefli","year":"2025","unstructured":"Yousefli Z, et al. Recent advances of Circulating biomarkers with potential diagnostic, prognostic, and therapeutic value in pancreatic cancer: limitations of clinical application. Pathol Res Pract. 2025;272:156045.","journal-title":"Pathol Res Pract"},{"key":"4215_CR27","doi-asserted-by":"crossref","unstructured":"Ren S et al. The role of novel biomarkers in the early diagnosis of pancreatic cancer: A systematic review and meta-analysis. PLoS ONE. 2025;20(5):e0322720.","DOI":"10.1371\/journal.pone.0322720"},{"issue":"12","key":"4215_CR28","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/cac2.12204","volume":"41","author":"J Yang","year":"2021","unstructured":"Yang J, et al. Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review. Cancer Commun (Lond). 2021;41(12):1257\u201374.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"4215_CR29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41392-021-00659-4","volume":"6","author":"S Wang","year":"2021","unstructured":"Wang S, et al. The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives. Signal Transduct Target Ther. 2021;6(1):249.","journal-title":"Signal Transduct Target Ther"},{"key":"4215_CR30","doi-asserted-by":"crossref","first-page":"104807","DOI":"10.1016\/j.critrevonc.2025.104807","volume":"212","author":"M Toledano-Fonseca","year":"2025","unstructured":"Toledano-Fonseca M, et al. Unveilling the potential of liquid biopsy in pancreatic cancer for molecular diagnosis and treatment guidance. Crit Rev Oncol Hematol. 2025;212:104807.","journal-title":"Crit Rev Oncol Hematol"},{"key":"4215_CR31","doi-asserted-by":"crossref","unstructured":"Rushton A et al. A Review of Circulating Tumour Cell Enrichment Technologies. Cancers. 2021;13(5):1\u201333.","DOI":"10.3390\/cancers13050970"},{"issue":"1","key":"4215_CR32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12943-023-01870-3","volume":"22","author":"K Wang","year":"2023","unstructured":"Wang K, et al. Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation. Mol Cancer. 2023;22(1):167.","journal-title":"Mol Cancer"},{"issue":"1","key":"4215_CR33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s13046-024-03166-w","volume":"43","author":"KL Reese","year":"2024","unstructured":"Reese KL, Pantel K, Smit DJ. Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer - a comprehensive review. J Exp Clin Cancer Res. 2024;43(1):250.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4215_CR34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12943-021-01309-7","volume":"20","author":"J Hou","year":"2021","unstructured":"Hou J, Li X, Xie KP. Coupled liquid biopsy and bioinformatics for pancreatic cancer early detection and precision prognostication. Mol Cancer. 2021;20(1):34.","journal-title":"Mol Cancer"},{"key":"4215_CR35","doi-asserted-by":"crossref","first-page":"217350","DOI":"10.1016\/j.canlet.2024.217350","volume":"610","author":"B Yu","year":"2025","unstructured":"Yu B, Shao S, Ma W. Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy. Cancer Lett. 2025;610:217350.","journal-title":"Cancer Lett"},{"key":"4215_CR36","doi-asserted-by":"crossref","first-page":"175883592311576","DOI":"10.1177\/17588359231157651","volume":"15","author":"JT Topham","year":"2023","unstructured":"Topham JT, Renouf DJ, Schaeffer DF. Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinoma. Ther Adv Med Oncol. 2023;15:17588359231157651.","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"4215_CR37","doi-asserted-by":"crossref","first-page":"27296","DOI":"10.1038\/s41598-024-76903-y","volume":"14","author":"C Maulat","year":"2024","unstructured":"Maulat C, et al. Prognostic impact of Circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients. Sci Rep. 2024;14(1):27296.","journal-title":"Sci Rep"},{"issue":"1","key":"4215_CR38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s40364-023-00528-y","volume":"11","author":"MV Garc\u00eda-Ortiz","year":"2023","unstructured":"Garc\u00eda-Ortiz MV, et al. Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects. Biomark Res. 2023;11(1):88.","journal-title":"Biomark Res"},{"key":"4215_CR39","doi-asserted-by":"crossref","unstructured":"Liu P et al. Emerging role of different DNA methyltransferases in the pathogenesis of cancer. Front Pharmacol. 2022;13:958146.","DOI":"10.3389\/fphar.2022.958146"},{"key":"4215_CR40","doi-asserted-by":"crossref","unstructured":"Mohd Kamal K et al. The role of DNA methylation and DNA methyltransferases (DNMTs) as potential biomarker and therapeutic target in non-small cell lung cancer (NSCLC). Heliyon. 2024 Sep 27;10(19):e38663.","DOI":"10.1016\/j.heliyon.2024.e38663"},{"key":"4215_CR41","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1515\/cclm-2023-1327","volume":"62","author":"B Wang","year":"2024","unstructured":"Wang B, et al. Circulating tumor DNA methylation: a promising clinical tool for cancer diagnosis and management. Clin Chem Lab Med (CCLM). 2024;62:2111\u201327.","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"4215_CR42","doi-asserted-by":"crossref","unstructured":"Stubbe B et al. Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma. Cancers. 2021;13(22):5717.","DOI":"10.3390\/cancers13225717"},{"key":"4215_CR43","doi-asserted-by":"crossref","unstructured":"Semenkovich N et al. Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA. J Immunother Cancer. 2023;11(1):e007063.","DOI":"10.1136\/jitc-2022-006284"},{"key":"4215_CR44","doi-asserted-by":"crossref","unstructured":"Lin Z et al. Early Detection of Pancreatic Cancer: Current Advances and Future Opportunities. Biomedicines. 2025;13(7):1733.","DOI":"10.3390\/biomedicines13071733"},{"issue":"1","key":"4215_CR45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13045-021-01149-4","volume":"14","author":"M Reese","year":"2021","unstructured":"Reese M, Dhayat SA. Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications. J Hematol Oncol. 2021;14(1):141.","journal-title":"J Hematol Oncol"},{"key":"4215_CR46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2025.01.072","volume":"380","author":"R Hasan","year":"2025","unstructured":"Hasan R, et al. Small extracellular vesicles (sEVs) in pancreatic cancer progression and diagnosis. J Control Release. 2025;380:269\u201382.","journal-title":"J Control Release"},{"issue":"5","key":"4215_CR47","doi-asserted-by":"crossref","first-page":"189153","DOI":"10.1016\/j.bbcan.2024.189153","volume":"1879","author":"RN Fuller","year":"2024","unstructured":"Fuller RN, et al. Small non-coding RNAs and pancreatic ductal adenocarcinoma: linking diagnosis, pathogenesis, drug resistance, and therapeutic potential. Biochim Biophys Acta Rev Cancer. 2024;1879(5):189153.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"5\u20136","key":"4215_CR48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/15384047.2021.1941584","volume":"22","author":"A Tarasiuk","year":"2021","unstructured":"Tarasiuk A, et al. Biomarkers for early detection of pancreatic cancer \u2013 miRNAs as a potential diagnostic and therapeutic tool? Cancer Biol Ther. 2021;22(5\u20136):347\u201356.","journal-title":"Cancer Biol Ther"},{"key":"4215_CR49","doi-asserted-by":"crossref","unstructured":"Zhao X, Ren Y, Lu Z. Potential diagnostic and therapeutic roles of exosomes in pancreatic cancer. Biochim Biophys Acta Rev Cancer. 2020;1874(2):188414.","DOI":"10.1016\/j.bbcan.2020.188414"},{"issue":"1","key":"4215_CR50","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.gastro.2023.09.050","volume":"166","author":"C Xu","year":"2024","unstructured":"Xu C, et al. A Circulating panel of circrna biomarkers for the noninvasive and early detection of pancreatic ductal adenocarcinoma. Gastroenterology. 2024;166(1):178\u2013e19016.","journal-title":"Gastroenterology"},{"key":"4215_CR51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.semcancer.2020.10.001","volume":"75","author":"GG Sharma","year":"2021","unstructured":"Sharma GG, et al. Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma. Semin Cancer Biol. 2021;75:153\u201368.","journal-title":"Semin Cancer Biol"},{"key":"4215_CR52","first-page":"0918","volume":"8","author":"Z Li","year":"2025","unstructured":"Li Z, et al. A circular RNA promotes tumor metastasis through stabilizing MSI2 protein in pancreatic ductal adenocarcinoma. Res (Wash D C). 2025;8:0918.","journal-title":"Res (Wash D C)"},{"issue":"1","key":"4215_CR53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-021-01481-w","volume":"21","author":"CH Wong","year":"2022","unstructured":"Wong CH, et al. CircRTN4 promotes pancreatic cancer progression through a novel CircRNA-miRNA-lncRNA pathway and stabilizing epithelial-mesenchymal transition protein. Mol Cancer. 2022;21(1):10.","journal-title":"Mol Cancer"},{"issue":"7","key":"4215_CR54","doi-asserted-by":"crossref","first-page":"101090","DOI":"10.1016\/j.tranon.2021.101090","volume":"14","author":"M Mortoglou","year":"2021","unstructured":"Mortoglou M, et al. Non-coding RNAs in pancreatic ductal adenocarcinoma: new approaches for better diagnosis and therapy. Transl Oncol. 2021;14(7):101090.","journal-title":"Transl Oncol"},{"key":"4215_CR55","doi-asserted-by":"crossref","unstructured":"Sturm N, Ettrich TJ, Perkhofer L. The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy. Cancers (Basel). 2022;14(1):217.","DOI":"10.3390\/cancers14010217"},{"issue":"1","key":"4215_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-021-00806-y","volume":"20","author":"W Zhang","year":"2022","unstructured":"Zhang W, et al. Small extracellular vesicles: from mediating cancer cell metastasis to therapeutic value in pancreatic cancer. Cell Commun Signal. 2022;20(1):1.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"4215_CR57","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12935-024-03456-5","volume":"24","author":"C Qin","year":"2024","unstructured":"Qin C, et al. The systematic role of pancreatic cancer exosomes: distant communication, liquid biopsy and future therapy. Cancer Cell Int. 2024;24(1):264.","journal-title":"Cancer Cell Int"},{"issue":"12","key":"4215_CR58","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/cac2.12204","volume":"41","author":"J Yang","year":"2021","unstructured":"Yang J, et al. Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review. Cancer Commun. 2021;41(12):1257\u201374.","journal-title":"Cancer Commun"},{"key":"4215_CR59","doi-asserted-by":"crossref","unstructured":"Dieli R et al. The oncoprotein mucin 1 in pancreatic cancer onset and progression: potential clinical implications. Biomolecules. 2025;15(2):275.","DOI":"10.3390\/biom15020275"},{"key":"4215_CR60","doi-asserted-by":"crossref","unstructured":"He W et al. Early-Stage Pancreatic Cancer Diagnosis: Serum Biomarkers and the Potential for Aptamer-Based Biosensors. Molecules. 2025;30(9):2012.","DOI":"10.3390\/molecules30092012"},{"key":"4215_CR61","doi-asserted-by":"crossref","unstructured":"SStefanoudakis D et al. Emerging Tumor Biomarkers in Pancreatic Cancer and Their Clinical Implications. Curr Issues Mol Biol. 2025;47(5):347.","DOI":"10.3390\/cimb47050347"},{"key":"4215_CR62","first-page":"511","volume":"19","author":"R Abdel-Razeq","year":"2025","unstructured":"Abdel-Razeq R, et al. Enhancing early detection of pancreatic cancer in genetically predisposed individuals: integrating advanced imaging modalities with emerging biomarkers and liquid biopsy. Biologics. 2025;19:511\u201323.","journal-title":"Biologics"},{"issue":"48","key":"4215_CR63","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1038\/s41388-022-02493-6","volume":"41","author":"I Lakshmanan","year":"2022","unstructured":"Lakshmanan I, et al. Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma. Oncogene. 2022;41(48):5147\u201359.","journal-title":"Oncogene"},{"key":"4215_CR64","doi-asserted-by":"crossref","unstructured":"Manne A et al. Predictive Value of MUC5AC Signature in Pancreatic Ductal Adenocarcinoma: A Hypothesis Based on Preclinical Evidence. Int J Mol Sci. 2023;24(9):8087.","DOI":"10.3390\/ijms24098087"},{"key":"4215_CR65","doi-asserted-by":"crossref","unstructured":"Manne A et al. Understanding the Clinical Impact of MUC5AC Expression on Pancreatic Ductal Adenocarcinoma. Cancers (Basel). 2021;13(12):3059.","DOI":"10.3390\/cancers13123059"},{"issue":"12","key":"4215_CR66","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1007\/s12094-020-02372-0","volume":"22","author":"D Kriz","year":"2020","unstructured":"Kriz D, Ansari D, Andersson R. Potential biomarkers for early detection of pancreatic ductal adenocarcinoma. Clin Transl Oncol. 2020;22(12):2170\u20134.","journal-title":"Clin Transl Oncol"},{"issue":"2","key":"4215_CR67","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/MPA.0b013e318053eae2","volume":"35","author":"W Jelski","year":"2007","unstructured":"Jelski W, Chrostek L, Szmitkowski M. The activity of class I, II, III, and IV of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in pancreatic cancer. Pancreas. 2007;35(2):142\u20136.","journal-title":"Pancreas"},{"issue":"8","key":"4215_CR68","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1007\/s10620-007-0144-3","volume":"53","author":"W Jelski","year":"2008","unstructured":"Jelski W, Zalewski B, Szmitkowski M. Alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the Sera of patients with pancreatic cancer. Dig Dis Sci. 2008;53(8):2276\u201380.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"4215_CR69","first-page":"255","volume":"20","author":"W Jelski","year":"2011","unstructured":"Jelski W, et al. Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) as candidates for tumor markers in patients with pancreatic cancer. J Gastrointestin Liver Dis. 2011;20(3):255\u20139.","journal-title":"J Gastrointestin Liver Dis"},{"key":"4215_CR70","doi-asserted-by":"crossref","unstructured":"Aslanian HR, Lee JH, Canto MI. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review. Gastroenterology. 2020;159(1):358\u201362.","DOI":"10.1053\/j.gastro.2020.03.088"},{"key":"4215_CR71","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10689-024-00380-5","volume":"23","author":"K Overbeek","year":"2024","unstructured":"Overbeek K, Cahen D, Bruno M. The role of endoscopic ultrasound in the detection of pancreatic lesions in high-risk individuals. Fam Cancer. 2024;23:279\u201393.","journal-title":"Fam Cancer"},{"key":"4215_CR72","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez-Maldonado E et al. Clinical Application of Liquid Biopsy in Pancreatic Cancer: A Narrative Review. Int J Mol Sci. 2024;25(3):1640.","DOI":"10.3390\/ijms25031640"},{"key":"4215_CR73","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/cas.16104","volume":"115","author":"MR Lee","year":"2024","unstructured":"Lee MR, et al. Application of plasma Circulating KRAS mutations as a predictive biomarker for targeted treatment of pancreatic cancer. Cancer Sci. 2024;115:1283\u201395.","journal-title":"Cancer Sci"},{"key":"4215_CR74","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3892\/ol.2020.11691","volume":"20","author":"L Wu","year":"2020","unstructured":"Wu L, et al. Circulating Exosomal MicroRNAs as novel potential detection biomarkers in pancreatic cancer. Oncol Lett. 2020;20:1432\u201340.","journal-title":"Oncol Lett"},{"key":"4215_CR75","doi-asserted-by":"crossref","unstructured":"Rodrigues E et al. Dual-Emitting Molecularly Imprinted Nanopolymers for the Detection of CA19-9. Biomedicines. 2025;13(7):1629.","DOI":"10.3390\/biomedicines13071629"},{"key":"4215_CR76","doi-asserted-by":"crossref","unstructured":"Fathi S et al. A miRNA Signature for Non-Invasive Colorectal Cancer Diagnosis in Morocco: miR-21, miR-29a and miR-92a. Noncoding RNA. 2025;11(2):26.","DOI":"10.3390\/ncrna11020026"},{"key":"4215_CR77","doi-asserted-by":"crossref","unstructured":"Risha Y et al. The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers. Sci Rep. 2020;10(1):13572.","DOI":"10.1038\/s41598-020-70393-4"},{"key":"4215_CR78","doi-asserted-by":"crossref","unstructured":"Gostomczyk K et al. Biomarkers for the detection of circulating tumor cells. Exp Cell Res. 2025;448(1):114555.","DOI":"10.1016\/j.yexcr.2025.114555"},{"key":"4215_CR79","doi-asserted-by":"crossref","unstructured":"Liu Z et al. ITRAQ and PRM-based quantitative saliva proteomics in gastric cancer: biomarker discovery. Front Mol Biosci. 2025;12:1640508.","DOI":"10.3389\/fmolb.2025.1640508"},{"key":"4215_CR80","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/cac2.12204","volume":"41","author":"J Yang","year":"2021","unstructured":"Yang J, et al. Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review. Cancer Commun. 2021;41:1257\u201374.","journal-title":"Cancer Commun"},{"issue":"1","key":"4215_CR81","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13098-025-01750-4","volume":"17","author":"J Yang","year":"2025","unstructured":"Yang J, et al. Targeting early diagnosis and treatment of pancreatic cancer among the diabetic population: a comprehensive review of biomarker screening strategies. Diabetol Metab Syndr. 2025;17(1):176.","journal-title":"Diabetol Metab Syndr"},{"key":"4215_CR82","doi-asserted-by":"crossref","unstructured":"Qin W et al. VNN1 overexpression in pancreatic cancer cells inhibits paraneoplastic islet function by increasing oxidative stress and inducing \u03b2\u2011cell dedifferentiation. Oncol Rep. 2023;49(6):120.","DOI":"10.3892\/or.2023.8557"},{"issue":"1","key":"4215_CR83","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/s12885-023-11009-8","volume":"23","author":"WC Liao","year":"2023","unstructured":"Liao WC, et al. S100A8, S100A9 and S100A8\/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia. BMC Cancer. 2023;23(1):513.","journal-title":"BMC Cancer"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04215-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04215-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04215-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:55:40Z","timestamp":1771419340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04215-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4215"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04215-8","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}